# EDGAR Filing Document

**Accession Number:** 0001115864
**File Stem:** 0001477932-26-003119
**Filing Date:** 2026-5
**Character Count:** 58772
**Document Hash:** 91cca1a2d4a7352675a8c2a492cec3a4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-26-003119.hdr.sgml**: 20260514

**ACCESSION NUMBER**: 0001477932-26-003119

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 39

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260514

**DATE AS OF CHANGE**: 20260514

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ECOMINAS CORP.
- **CENTRAL INDEX KEY:** 0001115864
- **STANDARD INDUSTRIAL CLASSIFICATION:** MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 650790369
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-30839
- **FILM NUMBER:** 26978832

**BUSINESS ADDRESS:**
- **STREET 1:** 4100 EASTON DRIVE SUITE 111
- **CITY:** BAKERSFIELD
- **STATE:** CA
- **ZIP:** 93309
- **BUSINESS PHONE:** 646-768-8417

**MAIL ADDRESS:**
- **STREET 1:** 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** International Luxury Products, Inc.
- **DATE OF NAME CHANGE:** 20200909

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DERMALAY INDUSTRIES INC
- **DATE OF NAME CHANGE:** 20000530

?xml version='1.0' encoding='ASCII'? ilxp_10q.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended: **<u>March 31, 2026</u>**

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ____________ to ____________.

---

| |
|:---|
| **ECOMINAS CORP.** |
| (Exact name of registrant as specified in its charter)  |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;**Nevada** | **000-30839** | **N/A** |
| (State or other jurisdiction <br>of Incorporation) | (Commission <br>File Number) | (IRS Employer <br>Identification No.) |

---

**4100 Easton Drive Ste 111**

**<u>Bakersfield</u>, <u>CA 93309</u>**

(Address of principal executive offices, including zip code.)

**<u>416-825-9367</u>**

(Telephone number, including area code)

Securities registered under Section 12(b) of the Act: **None**

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒&nbsp;&nbsp;&nbsp;&nbsp; No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer  | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the Company has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐&nbsp;&nbsp;&nbsp;&nbsp; No ☒

As of May 14, 2026, the registrant had 107,670,830 shares of common stock issued and outstanding.

**ECOMINAS CORP.**

 **FORM 10-Q**

Index

---

| | | |
|:---|:---|:---|
| **[PART I. FINANCIAL INFORMATION](#p1)** | **[PART I. FINANCIAL INFORMATION](#p1)** |  |
| [Item 1.](#i1) | **[Condensed Financial Statements.](#i1)** | 4 |
|  | [CONDENSED BALANCE SHEETS](#bs) | 5 |
|  | [CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)](#so) | 6 |
|  | [CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)](#CF) | 7 |
|  | [CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)](#SE) | 8 |
|  | [NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)](#NT) | 9 |
| [Item 2.](#i2) | **[Management's Discussion and Analysis of Financial Conditions and Results of Operations.](#i2)** | 14 |
| [Item 3.](#i3) | **[Quantitative and Qualitative Disclosures about Market Risk.](#i3)** | 15 |
| [Item 4.](#i4) | **[Controls and Procedures.](#i4)** | 15 |
| **[PART II. OTHER INFORMATION](#p2)** | **[PART II. OTHER INFORMATION](#p2)** |  |
| [Item 1.](#p2i1) | **[Legal Proceedings.](#p2i1)** | 18 |
| [Item 1A.](#p2i1a) | **[Risk Factors.](#p2i1a)** | 18 |
| [Item 2.](#p2i2) | **[Unregistered Sales of Equity Securities and Use of Proceeds.](#p2i2)** | 18 |
| [Item 3.](#p2i3) | **[Defaults Upon Senior Securities.](#p2i3)** | 18 |
| [Item 4.](#p2i4) | **[Mine Safety Disclosures.](#p2i4)** | 18 |
| [Item 5.](#p2i5) | **[Other Information.](#p2i5)** | 18 |
| [Item 6.](#p2i6) | **[Exhibits.](#p2i6)** | 19 |

---

---

| |
|:---|
| 2 |
| *[**Table of Contents**](#toc)* |

---

**SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION**

This quarterly report on Form 10-Q and other publicly available documents, including the documents incorporated herein by reference, contain, and our officers and representatives may from time to time make, "forward-looking" statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "believe," "expect," "future," "likely," "may," "plan," "seek," "will" and similar references to future periods actions or results. Examples of forward-looking statements include our prospects for one or more future material transactions, potential sources of financing, and expenses for future periods.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

Any forward-looking statement made by us in this quarterly report on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Factors that could cause or contribute to such differences may include, but are not limited to, those described under the heading *"Risk Factors"* which may be included in the Company's Registration Statement on Form 10 as previously filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. The Company undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that may subsequently arise. Readers are urged to carefully review and consider the various disclosures made by the Company in this report and in the Company's other reports filed with the Commission that advise interested parties of the risks and factors that may affect the Company's business.

---

| |
|:---|
| 3 |
| *[**Table of Contents**](#toc)* |

---

**PART I. FINANCIAL INFORMATION**

**Item 1. Condensed Financial Statements.**

The accompanying unaudited condensed financial statements have been prepared by management and have not been reviewed by the Company's independent auditors.

The condensed financial statements include:

---

| |
|:---|
| Condensed Balance Sheets as of March 31, 2026 and December 31, 2025 |
| Condensed Statements of Operations for the three months ended March 31, 2026 and 2025 |
| Condensed Statements of Cash Flows for the three months ended March 31, 2026 and 2025 |
| Condensed Statements of Changes in Stockholders' Equity |
| Notes to Condensed Financial Statements |

---

---

| |
|:---|
| 4 |
| *[**Table of Contents**](#toc)* |

---

ECOMINAS CORP.

(FKA INTERNATIONAL LUXURY PRODUCTS, INC.,)

CONDENSED BALANCE SHEETS

---

| | | |
|:---|:---|:---|
| ASSETS | March 31, <br>2026<br>(UNAUDITED) | December 31, <br>2025<br>(AUDITED) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash | $- | $- |
| Total assets | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $- | $- |
| LIABILITIES AND STOCKHOLDERS' DEFICIT |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $238142 | $239578 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable | 150529 | 115405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable - related party | 68785 | 68785 |
| &nbsp;&nbsp;&nbsp;&nbsp;Due to related parties | 5293 | 5293 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 462749 | 429061 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 462749 | 429061 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commitments and Contingencies (Note 6) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series A Preferred stock, par value $0.0001 per share; 10,000,000 authorized and 10,000 and 10,000 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series B Preferred stock, par value $0.0001 per share; 10,000,000 authorized and 5,000,000 and 5,000,000 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 500 | 500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common Shares 700,000,000 authorized shares, par value $0.0001 107,670,830 and 107,670,830 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 10768 | 10768 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 5014863 | 5014863 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (5488880) | (5455192) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' deficit | (462749) | (429061) |
| Total liabilities and stockholders' deficit | $- | $- |

---

The accompanying notes are an integral part of these unaudited financial statements.

---

| |
|:---|
| 5 |
| *[**Table of Contents**](#toc)* |

---

ECOMINAS CORP.

(FKA INTERNATIONAL LUXURY PRODUCTS, INC.,)

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

---

| | | |
|:---|:---|:---|
|  | For the three months ended  | For the three months ended  |
|  | March 31  | March 31  |
|  | 2026 | 2025 |
| Sales  | $- | $- |
| Operating expenses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees  | 29551 | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative  | 1284 | 594 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 30835 | 10594 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (30835) | (10594) |
| Other expenses  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense  | (2853) | (2384) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other expenses  | (2853) | (2384) |
| Net loss before tax provision  | (33688) | (12978) |
| Tax provision  | - | - |
| Net loss  | $(33688) | $(12978) |
| Net loss per common share: basic and diluted | $(0.00) | $(0.00) |
| Weighted average common shares outstanding - basic and diluted  | 107670830 | 107670830 |

---

The accompanying notes are an integral part of these unaudited financial statements.

---

| |
|:---|
| 6 |
| *[**Table of Contents**](#toc)* |

---

ECOMINAS CORP.

(FKA INTERNATIONAL LUXURY PRODUCTS, INC.,)

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

---

| | | |
|:---|:---|:---|
|  | For the three months ended | For the three months ended |
|  | March 31, <br>2026 | March 31, <br>2025 |
| Cash Flows from Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(33688) | $(12978) |
| Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |
| Changes in assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (1436) | 2384 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (35124) | (10594) |
| Cash Flows from Financing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from notes payable | 35124 | 10594 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 35124 | 10594 |
| Net decrease in cash | $- | - |
| Cash, beginning of period | - | - |
| Cash, end of period | $- | $- |
| Supplemental disclosure of cash flow information |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $- | $- |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for taxes | $- | $- |

---

The accompanying notes are an integral part of these unaudited financial statements.

---

| |
|:---|
| 7 |
| *[**Table of Contents**](#toc)* |

---

ECOMINAS CORP.

(FKA INTERNATIONAL LUXURY PRODUCTS, INC.,)

CONDENSED STATEMENT OF STOCKHOLDERS' DEFICIT

(UNAUDITED)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Series A<br>Preferred<br>Shares | Series B<br>Preferred<br>Shares | <br><br>Par Value | <br>Common<br>Shares | <br><br>Par Value | <br>Paid-In<br>Capital | <br>Accumulated<br>Deficit | Total<br>Stockholders'<br>Deficit |
| Balance, December 31, 2025 | 10000 | 5000000 | $500 | 107670830 | $10768 | $5014863 | $(5455192) | $(429061) |
| Net loss |  |  |  |  |  |  | (33688) | (33688) |
| Balance, March 31, 2026 | 10000 | 5000000 | 500 | 107670830 | 10768 | 5014863 | (5488880) | (462749) |
| Balance, December 31, 2024 | 10000 | 5000000 | 500 | 107670830 | 10768 | 5014863 | (5309191) | (283060) |
| Net loss |  |  |  |  |  |  | (12978) | (12978) |
| Balance, March 31, 2025 | 10000 | 5000000 | $500 | 107670830 | $10768 | $5014863 | $(5322169) | $(296038) |

---

The accompanying notes are an integral part of these unaudited financial statements.

---

| |
|:---|
| 8 |
| *[**Table of Contents**](#toc)* |

---

**ECOMINAS CORP.** 

**(FKA INTERNATIONAL LUXURY PRODUCTS, INC.,)**

**NOTES TO CONDENSED FINANCIAL STATEMENTS**

**March 31, 2026** 

**NOTE 1 – NATURE OF BUSINESS AND OPERATIONS**

**Organization** 

The Company was incorporated on August 22, 1995 as a Nevada corporation under the name H. Herbig Land & Livestock Incorporated. From the date of incorporation to December 2, 1997 the Company had no significant operating activities. On December 2, 1997, the Company entered a purchase agreement with Mr. William E. Edwards to purchase the name Dermalay Industries, Inc., and inventory owned by Mr. Edwards in exchange for 2,550,000 shares of common stock. The Company is deemed to have entered the development stage effective December 2, 1997.

On May 12, 2023, the Company's Board of Directors approved a One for Three Hundred (1-for-300) Reverse Stock Split of the issued and outstanding shares of Common Stock. As of the date of filing the reverse split has not been approved by FINRA and as such the financial statements have not been retroactively restated to reflect the split.

On May 13, 2023, the Company filed Certificate of Change to its Articles of Incorporation, as amended, with the Secretary of Nevada to change the Company's corporate name to Maya Innovations Corp.

On March 20, 2023, the Company entered into an Asset Purchase Agreement ("Purchase Agreement"), by and among the Company, on the one hand, ("Buyer"), and Maya Innovations, LLC ("MILLC") and Maya Praveen Kumar, an individual ("Kumar") and the sole-officer, director, and shareholder of MILLC, on the other hand (collectively, MILLC and Kumar are hereinafter referred to as the "Seller") whereby the Company acquired various artificial intelligence related assets from the Seller for use in the healthcare industry. On September 15, 2023, the Company, and Maya Praveen Kumar, an individual ("Maya") entered into an Unwind Agreement and Mutual Release (the "Unwind Agreement"), for the purpose of unwinding, and rendering void, the Asset Purchase Agreement ("Original APA") executed by and between the Company and Maya on March 20, 2023. The Parties mutually and voluntarily agreed to unwind the transaction contemplated by the Original APA. Accordingly, the Company returned all the Assets acquired per the Original APA once Maya has cancelled, and returned to the Company's treasury, the 3,000,000 restricted shares of the Company's common stock and 1,000,000 shares of the Company's Series A Preferred Stock that were issued per the terms of the Original APA.

On the same day the Company entered into an Asset Purchase Agreement ("Purchase Agreement"), by and among the Company and Pure North Analytics, an unincorporated company based out of Dubai ("PNA") and Tejas Bansilal Parikh, an individual ("Parikh") (collectively, PNA and Parikh are hereinafter referred to as the "Seller") whereby the Company acquired various artificial intelligence related assets from the Seller relating to artificial intelligence tailored for financial markets. Specifically, PNA's expertise lies in predicting future share prices for Fortune 1000 companies that adhere to ESG (Environmental, Social, and Governance) standards, which significantly influence investor decisions. This tool can be offered by brokerages and financial institutions to their clients via subscription, empowering them to make well-informed investment choices. Collectively, all intellectual property, proprietary and nonproprietary technology, know-how, and all other assets of the Seller that maybe, directly, or indirectly, applied to the artificial intelligence field insofar as the financial industry are referred to hereinafter as the "Acquired Assets." In exchange for the Acquired Assets, the Company issued 6,000,000 restricted shares of its common stock (the "Common Shares"). Each of the Corporation and Seller shall make customary representations, warranties, covenants, and indemnities in connection with the Purchase Agreement Pursuant to the terms of the Purchase Agreement.

In connection with the foregoing, on September 26, 2023, the Company entered into an Executive Employment Agreement (the "Employment Agreement") with Tejas Bansilal Parikh (the "Mr. Parikh") whereby Mr. Parikh has agreed to serve as the Company's Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary, and as Chairman of the Company's Board of Directors.

Additionally, the Company received notice of resignation from Andrew Gaudet ("Gaudet") from the positions of President, Chief Executive Officer, Treasurer, Chief Financial Officer, and, Secretary of the Company (the "Resignation"). Gaudet's resignation from such positions was not the result of any disagreements between Gaudet and the Company relating to the Company's operations, policies, or practices.

---

| |
|:---|
| 9 |
| *[**Table of Contents**](#toc)* |

---

Gaudet shall retain his position as a member of the Company's Board of Directors until his resignation or until a successor is duly appointed at a meeting of the Company's Shareholders.

On September 21, 2023, the Company's Board of Directors, approved changing the Company name from Maya Innovations Corp. to Pure North Analytics Corp.

On November 16, 2023, the Company's Board of Directors, approved changing the Company name back to International Luxury Products, Inc.

**BASIS OF PRESENTATION** 

The accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States. Management is of the opinion that all necessary adjustments have been made to make these interim financial statements not misleading.

**NOTE 2 – GOING CONCERN**

The accompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States ("GAAP") on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During the three months ended March 31, 2026, the Company incurred net losses of $33,688, and accumulated deficits of $5,488,880. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

We are entirely dependent on our ability to attract and receive funding from either the sale of securities or outside sources such as private investment or a strategic partner. We currently have no firm agreements or arrangements with respect to any such financing and there can be no assurance that any needed funds will be available to us on acceptable terms or at all. The inability to obtain sufficient funding of our operations in the future will restrict our ability to grow and reduce our ability to continue to conduct business operations. Our failure to raise additional funds will adversely affect our business, and may require us to suspend our operations, which in turn may result in a loss to the purchasers of our common stock. If we are unable to obtain necessary financing, we will likely be required to curtail our development plans. Any additional equity financing may involve substantial dilution to our then existing stockholders.

**NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Use of Estimates**

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.

**Cash and Cash Equivalents**

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.

**Intangible assets** 

The Company follows Financial Accounting Standard Board's (FASB) Codification Topic 350-10 ("ASC 350-10"), "Intangibles – Goodwill and Other". According to this statement, intangible assets with indefinite lives are no longer subject to amortization, but rather an annual assessment of impairment by applying a fair-value based test. Under ASC 350-10, the carrying value of assets are calculated at the lowest level for which there are identifiable cash flows.

---

| |
|:---|
| 10 |
| *[**Table of Contents**](#toc)* |

---

**Income taxes**

The Company accounts for its income taxes in accordance with FASB Codification Topic ASC 740-10, "Income Taxes", which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

**Stock-based compensation**

The Company follows ASC 718-10, "Stock Compensation", which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, "Accounting for Stock-Based Compensation," and supersedes Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized.

**Concentration of Credit Risk**

The Company has no off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. The Company maintains all of its cash balances with two financial institutions in the form of demand deposits.

**Loss per Share**

The Company follows ASC Topic 260 to account for the earnings per share. Basic earnings per common share ("EPS") calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

**Revenue Recognition**

The Company recognizes revenue from its contracts with customers in accordance with ASC 606 – Revenue from Contracts with Customers. The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.

Revenue related to contracts with customers is evaluated utilizing the following steps: (i) Identify the contract, or contracts, with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; (v) Recognize revenue when the Company satisfies a performance obligation.

**Fair Value of Financial Instruments**

The Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are:

Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2 - Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument's anticipated life.

Level 3 - Inputs reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

---

| |
|:---|
| 11 |
| *[**Table of Contents**](#toc)* |

---

As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability ("an exit price") in an orderly transaction between market participants at the measurement date

The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company's financial instruments that could have been realized as of March 31, 2026 and December 31, 2025 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company's notes payable approximates the fair value of such instrument based upon management's best estimate of terms that would be available to the Company for similar financial arrangements at March 31, 2026 and December 31, 2025.

**Recent Accounting Pronouncements**

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. This ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company adopted the ASU and determined that its adoption did not have a material impact on the Company's consolidated financial statements and related disclosures. As defined in the ASU, operating segments are components of an enterprise about which discrete financial information is regularly provided to the CODM in making decisions on how to allocate resources and assess performance for the organization. The Company operates and manages its business as one reportable and operating segment. The Company's CODM is the Chief Executive Officer. The Company's CODM reviews consolidated operating results to make decisions about allocating resources and assessing performance for the entire Company.

The Company does not believe that other standards, which have been issued but are not yet effective, will have a significant impact on its financial statements.

**NOTE 4 –NOTES PAYABLE** 

Promissory notes payable as of March 31, 2026 and December 31, 2025 consists of the following:

---

| | |
|:---|:---|
| **March 31, 2026** | **December 31, 2025** |
| 8012 | 8012 |
| 3590 | 3590 |
| 5650 | 5650 |
| 5000 | 5000 |
| 10000 | 10000 |
| 8000 | 8000 |
| 7880 | 7880 |
| 10000 | 10000 |
| 3500 | 3500 |
| 750 | 750 |
| 169 | 169 |
| 3000 | 3000 |
| 10000 | 10000 |
| 1102 | 1102 |
| 6000 | 6000 |
| 3440 | 3440 |
| 10000 | 10000 |
| 594 | 594 |
| 4500 | 4500 |
| 5000 | 5000 |
| 5000 | 5000 |
| 700 | 700 |
| 3000 | 3000 |
| 518 | 518 |
| 349 |  |
| 34775 | - |
| $150529 | $115405 |

---

During the year ended March 31, 2026 and December 31, 2025, the Company had promissory notes amounting to $150,529 and $115,405 due to the same noteholder, respectively of which $35,124 were issued during the three months ended March 31, 2026 for general operating purposes. The notes carry an interest rate of 10% and are due upon demand.

During the year ended March 31, 2026 and 2025, the Company recorded interest expense related to these notes of $2,853 and $2,384, respectively.

**NOTE 5 – RELATED PARTY TRANSACTIONS**

*<u>NOTES PAYABLE – Related Party</u>*

Notes payable – Related party as of March 31, 2026 and December 31, 2025 consists of the following:

---

| | |
|:---|:---|
| **March 31, 2026** | **December 31, 2025** |
| $6910 | $6910 |
| 23247 | 23247 |
| 38628 | 38628 |
| $68785 | $68785 |

---

---

| |
|:---|
| 12 |
| *[**Table of Contents**](#toc)* |

---

As of March 31, 2026 and December 31, 2025, the Company had various promissory notes due to officers and shareholders amounting to $68,785. The notes carry an interest rate of 0% and are due upon demand.

*<u>Due to related Party</u>*

As of March 31, 2026 and December 31, 2025, the Company had amount due to related parties of $5,293 and $5,293, respectively. These advances carry 0% and are due upon demand.

**NOTE 6 - COMMITMENTS AND CONTINGENCIES**

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results.

**NOTE 7 – STOCKHOLDERS' EQUITY**

As of March 31, 2026 and December 31, 2025, the Company had 107,670,830 and 107,670,830 shares of common stock, 10,000 and 10,000 shares of Series A Preferred Stock, and 5,000,000 and 5,000,000 shares of Series B Preferred Stock issued and outstanding, respectively.

On May 12, 2023, the Company's Board of Directors approved a One for Three Hundred (1-for-300) Reverse Stock Split of the issued and outstanding shares of Common Stock. As of the date of filing the reverse split has not been approved by FINRA and as such the financial statements have not been retroactively restated to reflect the split.

On October 12, 2023, the Board of Directors authorize an amendment to the articles of Incorporation to specifically increase the authorized shares to One Billion (1,000,000,000), consisting of; (i) Seven Hundred Million (700,000,000) shares of Common Stock, par value $0.0001 per share, Three Hundred Million (300,000,000) shares of preferred stock, par value $0.0001 per share which are issuable in one or more Series; to designate 10,000,000 preferred shares as Series A Preferred Stock and, (iv) to designate 10,000,000 preferred shares as Series B Preferred Stock.

**NOTE 8 – SUBSEQUENT EVENTS**

In accordance with ASC 855 the Company's management reviewed all material events through May 14, 2026, and noted no material subsequent events

---

| |
|:---|
| 13 |
| *[**Table of Contents**](#toc)* |

---

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

**FORWARD-LOOKING STATEMENTS**

*The following discussion may contain forward-looking statements regarding the Company, its business prospects and its results of operations that are subject to certain risks and uncertainties posed by many factors and events that could cause the Company's actual business, prospects and results of operations to differ materially from those that may be anticipated by such forward-looking statements. These forward-looking statements reflect our view only as of the date of this report. The Company cannot guarantee future results, levels of activity, performance, or achievement. The Company does not undertake any obligation to update or correct any forward-looking statements.*

**Overview**

Results of Operations

Revenues

There was no revenue for the three months ended March 31, 2026 and 2025.

Operating Expenses

Operating expenses increased to $30,835 for the three months ended March 31, 2026, from $10,594 for the same period ended March 31, 2025.

Our operating expenses for all periods consisted mainly of professional fees and selling, general and administrative expenses. The increase in operating expenses was primarily a result of an increase in accounting fees during the three months ended March 31, 2026.

Other Income (Expenses)

We had other expenses of $2,853 for the three months ended March 31, 2026, as compared with other expenses of $2,384 for the three months ended March 31, 2025.

Our other expense for the three months ended March 31, 2026 and 2025 consisted mainly of interest expense in the amount of $2,853 and $2,384, respectively. The increase in interest expense is the result of the Company issuing additional notes during 2026

Net Loss

We recorded a net loss of $33,688 for the three months ended March 31, 2026, as compared with a net loss of $12,978 for the three months ended March 31, 2025. The increase in net loss is the result of the factors discussed above.

Liquidity and Capital Resources

The accompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States ("GAAP") on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During the three months ended March 31, 2026, the Company incurred a net loss of $33,688, and a accumulated deficit of $5,488,880. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

---

| |
|:---|
| 14 |
| *[**Table of Contents**](#toc)* |

---

We are entirely dependent on our ability to attract and receive funding from either the sale of securities or outside sources such as private investment or a strategic partner. We currently have no firm agreements or arrangements with respect to any such financing and there can be no assurance that any needed funds will be available to us on acceptable terms or at all. The inability to obtain sufficient funding of our operations in the future will restrict our ability to grow and reduce our ability to continue to conduct business operations. Our failure to raise additional funds will adversely affect our business, and may require us to suspend our operations, which in turn may result in a loss to the purchasers of our common stock. If we are unable to obtain necessary financing, we will likely be required to curtail our development plans. Any additional equity financing may involve substantial dilution to our then existing stockholders.

As of March 31, 2026, we had no assets of $0. Our total current liabilities as of March 31, 2026 were $462,749. We had a working capital deficit of $462,749 as of March 31, 2026, compared with a working capital deficit of $429,061 as of December 31, 2025.

Operating activities used $35,124 in cash for the three months ended March 31, 2026, as compared with $10,594 used for the three months ended March 31, 2025. Our negative operating cash flows for 2026 and 2025 was largely the result of our net loss for those quarters, mainly offset by changes in operating assets and liabilities and the amortization of debt discount and amortization.

We used no cash in investing activities for the three months ended March 31, 2026 and 2025.

Cash flow provided from financing activities was $35,124 for the three months ended March 31, 2026, as compared with $10,594 provided by cash flows for financing activities during the three months ended March 31, 2025.

The features of the debt instruments and payables concerning our financing activities are detailed in the footnotes to our financial statements.

Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through increased sales and debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional capital.

**Off Balance Sheet Arrangements**

As of March 31, 2026, there were no off-balance sheet arrangements.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

As a smaller reporting company, we are not required to provide the information required by this Item.

**ITEM 4. CONTROLS AND PROCEDURES**

**Management's Responsibility for Controls and Procedures**

The Company's management is responsible for establishing and maintaining adequate internal control over the Company's financial reporting. The Company's controls over financial reporting are designed under the supervision of the Company's Principal Executive Officer and Principal Financial Officer to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is accumulated and communicated to the Company's management, including the Company's principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

---

| |
|:---|
| 15 |
| *[**Table of Contents**](#toc)* |

---

**Evaluation of Disclosure Controls and Procedures**

Under the supervision and with the participation of our Principal Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act, as of March 31, 2026. Based on this evaluation, management concluded that our financial disclosure controls and procedures were not effective so as to timely record, process, summarize and report financial information required to be included on our SEC reports due to the Company's limited internal resources and lack of ability to have multiple levels of transaction review. However, as a result of our evaluation and review process, management believes that the financial statements and other information presented herewith are materially correct.

**Internal Control Over Financial Reporting**

As of March 31, 2026, under the supervision and with the participation of our management, we conducted an evaluation of the effectiveness of the design and operations of our internal control over financial reporting, as defined in Rules 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act of 1934 and based on the criteria for effective internal control described in *Internal Control – Integrated Framework* issued by the Committee of Sponsoring Organizations of the Treadway Commission (as revised). Based on our evaluation, management concluded that our internal control over financial reporting was not effective so as to timely record, process, summarize and report financial information required to be included on our Securities and Exchange Commission ("SEC") reports due to the Company's limited internal resources and lack of ability to have multiple levels of transaction review. However, as a result of our evaluation and review process, management believes that the financial statements and other information presented herewith are materially correct.

The management including its Principal Executive Officer/Principal Financial Officer, does not expect that its disclosure controls and procedures, or its internal controls over financial reporting will prevent all error and all fraud. A control system no matter how well conceived and operated, can provide only reasonable not absolute assurance that the objectives of the control system are met. Further, the design of the control system must reflect the fact that there are resource constraints, and the benefit of controls must be considered relative to their costs.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

The Company has limited resources and as a result, a material weakness in financial reporting currently exists, because of our limited resources and personnel, including those described below.

\* The Company has an insufficient quantity of dedicated resources and experienced personnel involved in reviewing and designing internal controls. As a result, a material misstatement of the interim and annual financial statements could occur and not be prevented or detected on a timely basis.

\* We have not achieved the optimal level of segregation of duties relative to key financial reporting functions.

\* We do not have an audit committee or an independent audit committee financial expert. While not being legally obligated to have an audit committee or independent audit committee financial expert, it is management's view that to have an audit committee, comprised of independent board members, and an independent audit committee financial expert is an important entity-level control over the Company's financial statements.

A material weakness is a deficiency (within the meaning of the Public Company Accounting Oversight Board (PCAOB) auditing standard 5) or combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. Management has determined that a material weakness exists due to a lack of segregation of duties, resulting from the Company's limited resources and personnel.

---

| |
|:---|
| 16 |
| *[**Table of Contents**](#toc)* |

---

**Remediation Efforts to Address Deficiencies in Internal Control Over Financial Reporting**

As a result of these findings, management, upon obtaining sufficient capital and operations, intends to take practical, cost-effective steps in implementing internal controls, including the possible remedial measures set forth below. As of March 31, 2026, we did not have sufficient capital and/or operations to implement any of the remedial measures described below.

\* Assessing the current duties of existing personnel and consultants, assigning additional duties to existing personnel and consultants, and, in a cost effective manner, potentially hiring additional personnel to assist with the preparation of the Company's financial statements to allow for proper segregation of duties, as well as additional resources for control documentation.

\* Assessing the duties of the existing officers of the Company and, in a cost effective manner, possibly promote or hire additional personnel to diversify duties and responsibilities of such executive officers.

\* Board to review and make recommendations to shareholders concerning the composition of the Board of Directors, with particular focus on issues of independence. The Board of Directors will consider nominating an audit committee and audit committee financial expert, which may or may not consist of independent members.

\* Interviewing and potentially hiring outside consultants that are experts in designing internal controls over financial reporting based on criteria established in Internal Control Integrated Framework issued by Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") (as revised).

**(b) Change in Internal Control Over Financial Reporting**

The Company has not made any change in our internal control over financial reporting during the period ended March 31, 2026.

---

| |
|:---|
| 17 |
| *[**Table of Contents**](#toc)* |

---

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings.**

We are not party to any material legal proceedings. From time to time, we may be involved in legal proceedings or subject to claims incident to the ordinary course of business. The outcome of litigation is inherently uncertain, and there can be no assurances that favorable outcomes will be obtained. In addition, regardless of the outcome, such proceedings or claims can have an adverse impact on us, which may be material because of defense and settlement costs, diversion of resources and other factors.

**Item 1A. Risk Factors.** 

The risks described under the heading "Risk Factors" in the Company's Registration Statement on Form 10, as amended, which was previously filed with the Securities and Exchange Commission, may cause or contribute to actual results differing materially from those anticipated. The risks and uncertainties described therein are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently deem immaterial, may also become important factors that adversely affect our business.

You should carefully read and consider such risks, together with all of the other information in our Registration Statement on Form 10 and in this Quarterly Report on Form 10-Q (including the disclosures in the section titled "Management's Discussion and Analysis of Financial Condition and Results of Operations" and in our condensed consolidated financial statements and related notes), and in the other documents that we file with the SEC.

There have been no material changes from the risk factors previously disclosed under the heading "Risk Factors" in our Registration Statement on Form 10, as amended.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) During the quarter ended March 31, 2026, there were no unregistered sales of our securities that were not previously reported in the Company's Registration Statement on Form 10 as filed with the SEC on February 24, 2026, and as amended and filed on April 9, 2026, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) None.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosures.**

Not Applicable.

**Item 5. Other Information.**

None

---

| |
|:---|
| 18 |
| *[**Table of Contents**](#toc)* |

---

**ITEM 6 - EXHIBITS**

---

| | |
|:---|:---|
| **Number**  | **Description of Exhibit** |
| [3.1](http://www.sec.gov/Archives/edgar/data/1115864/000147793226000980/ilxp_ex31.htm) | [Amended and Restated Articles of Incorporation (1)](http://www.sec.gov/Archives/edgar/data/1115864/000147793226000980/ilxp_ex31.htm) |
| [3.2](http://www.sec.gov/Archives/edgar/data/1115864/000147793226000980/ilxp_ex32.htm) | [Bylaws(1)](http://www.sec.gov/Archives/edgar/data/1115864/000147793226000980/ilxp_ex32.htm) |
| [31.1](ilxp_ex311.htm) | [Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rule 13A-14(A) Under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\*\*](ilxp_ex311.htm) |
| [32.1](ilxp_ex321.htm) | [Certification pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002. \*\*](ilxp_ex321.htm) |

---

---

| | |
|:---|:---|
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)# |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(1) Filed with the SEC on February 24, 2026 as an exhibit to our Registration Statement on Form 10-12G*

*\*\* Filed herewith*

*# The XBRL related information in Exhibit 101 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.*

---

| |
|:---|
| 19 |
| *[**Table of Contents**](#toc)* |

---

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | Ecominas Corp.  | Ecominas Corp.  |
| Date: May 14, 2026 | By: | */s/ Ricardo Enrique Silva Canelon* |
|  | Name: | *Ricardo Enrique Silva Canelon* |
|  | Title: | Chief Executive Officer & Chief Financial Officer |

---

20<br>

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION**

I, **Ricardo Enrique Silva Canelon**, Chief Executive Officer and Chief Financial Officer of **Ecominas Corp. (the "Registrant")**, certify that:

1. I have reviewed this Quarterly Report on **Form 10-Q** of the Registrant for the fiscal quarter ended **March 31, 2026**;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

---

| |
|:---|
| Dated: May 14, 2026 |
| */s/ Ricardo Enrique Silva Canelon* |
| Chief Executive Officer and Chief Financial Officer<br> (Principal executive, financial and accounting officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of **Ecominas Corp.** (the "Company") on Form 10-Q for the period ending March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, **Ricardo Enrique Silva Canelon**, Chief Executive Officer and Chief Financial Officer of **Ecominas Corp.**, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

**Ecominas Corp.**

---

| | | |
|:---|:---|:---|
| Dated: May 14, 2026 | By: | */s/ Ricardo Enrique Silva Canelon* |
|  |  | Chief Executive Officer and Chief Financial Officer |
|  |  | (Principal executive, financial and accounting officer) |

---